Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data

Jennifer S Lees; Jamie Crowther; Peter Hanlon; Elaine Butterly; S H Wild; Frances S Mair; Bruce Guthrie; Katie Gillies; Sofia Dias; Nicky J Welton; Srinivasa Vittal Katikireddi; David A. McAllister

doi:10.1136/bmjmed-2023-000732

Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data

Jennifer S Lees^*, Jamie Crowther, Peter Hanlon, Elaine Butterly, S H Wild, Frances S Mair, Bruce Guthrie, Katie Gillies, Sofia Dias, Nicky J Welton, Srinivasa Vittal Katikireddi, David A. McAllister

^*Corresponding author for this work

Centre for Reviews and Dissemination

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e000732
Number of pages	11
Journal	BMJ Medicine
Volume	3
DOIs	https://doi.org/10.1136/bmjmed-2023-000732
Publication status	Published - 3 May 2024

Bibliographical note

Access to Document

10.1136/bmjmed-2023-000732Licence: CC BY

Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data
© Author(s) (or their employer(s)) 2024.
Final published version, 910 KBLicence: CC BY

Cite this

Lees, J. S., Crowther, J., Hanlon, P., Butterly, E., Wild, S. H., Mair, F. S., Guthrie, B., Gillies, K., Dias, S., Welton, N. J., Katikireddi, S. V., & McAllister, D. A. (2024). Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data. BMJ Medicine, 3, Article e000732. https://doi.org/10.1136/bmjmed-2023-000732

@article{03bfdc74807e4856ad9d9d8d32555d48,

title = "Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data",

author = "Lees, {Jennifer S} and Jamie Crowther and Peter Hanlon and Elaine Butterly and Wild, {S H} and Mair, {Frances S} and Bruce Guthrie and Katie Gillies and Sofia Dias and Welton, {Nicky J} and Katikireddi, {Srinivasa Vittal} and McAllister, {David A.}",

note = "{\textcopyright} Author(s) (or their employer(s)) 2024. ",

year = "2024",

month = may,

day = "3",

doi = "10.1136/bmjmed-2023-000732",

language = "English",

volume = "3",

journal = "BMJ Medicine",

issn = "2754-0413",

}

Lees, JS, Crowther, J, Hanlon, P, Butterly, E, Wild, SH, Mair, FS, Guthrie, B, Gillies, K, Dias, S, Welton, NJ, Katikireddi, SV & McAllister, DA 2024, 'Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data', BMJ Medicine, vol. 3, e000732. https://doi.org/10.1136/bmjmed-2023-000732

TY - JOUR

T1 - Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions

T2 - meta-analysis of individual participant level data

AU - Lees, Jennifer S

AU - Crowther, Jamie

AU - Hanlon, Peter

AU - Butterly, Elaine

AU - Wild, S H

AU - Mair, Frances S

AU - Guthrie, Bruce

AU - Gillies, Katie

AU - Dias, Sofia

AU - Welton, Nicky J

AU - Katikireddi, Srinivasa Vittal

AU - McAllister, David A.

PY - 2024/5/3

Y1 - 2024/5/3

U2 - 10.1136/bmjmed-2023-000732

DO - 10.1136/bmjmed-2023-000732

M3 - Article

SN - 2754-0413

VL - 3

JO - BMJ Medicine

JF - BMJ Medicine

M1 - e000732

ER -